Now in its 13th year, the PanAgora Pharma CX Summit remains the premier meeting place for pharma marketing and customer experience leaders. The 2026 edition of the Pharma CX Summit is broken down into a HCP-focused CX Day (March 24th) and a Patient/Consumer-focused CX Day (March 25th), with plenty of comprehensive pharma CX content throughout both days.

This year's agenda will explore how pharma CX, marketing, and brand teams are leveraging AI, data, human-centricity, and design to optimize experiences for patients and HCPs in a real and measurable way.

Attendees of the Pharma CX Summit benefit from a lively and interactive conference environment that fosters peer-to-peer interaction, collaboration, and networking with over 65% of the 200+ attendees from pharma and med device companies.

Join the 4th Digital Biomarker Summit USA, which will bring industry thought leaders together in May 2026 to share updates in the digital health technology and digital biomarker space.

This year's one-day event will discuss how the industry can continue to collaborate on digital measurement and digital endpoints, share case studies on recent work on digital biomarkers in clinical trials, a future beyond digital endpoints, and the importance of working with patients to determine which measures matter.

Visit the website to submit your Interest in joining!

The Digital Breakthrough for Pharma Summit 2026 will focus on the evolving digital health landscape and the impact of novel technologies in the life sciences. Join us this June at BMS Princeton Pike to hear how digital health is impacting everything from patient monitoring to diagnosis and treatment and driving better health outcomes for patients across the board.

Join 25+ speakers and 200+ senior-level life sciences, research, drug development and digital health executives this June at BMS Princeton Pike to hear about the latest trends in digital health and AI and to network with peers and colleagues across the value chain.

The Digital Biomarkers Summit is the first global forum of its kind to focus on ways for pharma clinical trials to take advantage of new opportunities to collect better data and improve the patient experience; as well as how these new digital health tools supplement existing biomarker strategies.

Join 350+ global experts converging at the forefront of wearable technologies, data management, analytics, connected devices and biomarkers strategies in pharma clinical trials. If you’re involved with R&D, sales and marketing, information technology, data management, patient recruitment, biomarkers or health outcomes this is the place to be.

Building off of seven years of successful Digital Biomarkers in Clinical Trials Summit held annually at Roche in Basel (and two more virtually), don't miss the 9th Annual Digital Biomarkers in Clinical Trials Summit this June in Basel!

PanAgora Pharma and Roche are collaborating to present the 6th edition of the Clinical Trial Innovation Summit, an event highlighting the latest in clinical research innovation.

Join 250+ clinical research leaders this June to network, and learn the latest on how life sciences organizations are building more patient-centric clinical trials by improving patient diversity, engagement, retention, and recruitment.

Core themes for the 2025 conference agenda included:
• Delivering Human-Centered Clinical Trials (HC CTs)
• Enhancing Diversity, Equity & Inclusion in Clinical Trials
• Incorporating Lived Experiences and the Voice of the Patient into Clinical Trials
• The Latest Innovations in Virtual, Hybrid and Decentralized Trials
• Patient Collaboration: Involving Patients Early, Learning from Them, Scaling-Out
• Identifying Innovations & Technologies Accelerating Patient-Centric Trials

PanAgora Pharma and Genentech are collaborating to present the 3rd Annual Clinical Trial Innovation Summit. The 2026 edition will bring together 250+ clinical research leaders, and the conference agenda will focus on how life sciences organizations can build more patient-centric clinical trials by improving patient diversity, engagement, retention, and recruitment.

Core themes for previous conference agendas include:

• Delivering Human-Centered Clinical Trials (HC CTs)
• Enhancing Diversity, Equity & Inclusion in Clinical Trials
• Incorporating Lived Experiences and the Voice of the Patient into Clinical Trials
• The Latest Innovations in Virtual, Hybrid and Decentralized Trials
• Patient Collaboration: Involving Patients Early, Learning from Them, Scaling-Out
• Identifying Innovations & Technologies Accelerating Patient-Centric Trials

Building off of recent advancements in the field, the 9th Annual Digital Implementation Summit focuses on ways for life sciences to take advantage of new opportunities within digital health and digital measurement; as well as how these new data can supplement existing collection strategies to drive research forward in partnership with patients, clinicians and payers. The event focuses on transitioning validated digital measurements into digital products and digital therapeutics.

Join 30+ speakers, 150 senior-level pharma, clinical trials, technology and digital health executives in November 2026 at Pfizer in Cambridge to learn, network, develop and improve the way digital health measurement tools are being created, standardized, scaled and deployed in life sciences to improve data quality, improve patient experience & accelerate drug development.

The 2026 edition of the annual Pharma CX AI & Tech Summit will focus on how pharma brands are improving customer experiences by leveraging technology. The agenda covers topics like omnichannel and generative AI, but will also explore media strategy, field force technology, CXM, and much, much more. The goal of this event is to create a conference environment that focuses on peer-to-peer interaction, knowledge sharing, and networking.

Join 125+ pharma marketing & CX leaders on November 17th in Princeton, NJ for a 1-day pharma customer experience technology masterclass and discover how pharma brands are implementing AI and emering technologies to measurably improve the HCP and patient experience.